Ovintiv (NYSE:OVV) Bolsa

OVINTIV INC

Ovintiv

Ovintiv Inc is a North American oil and natural gas exploration and production company that is focused on developing its multi-basin portfolio of high-quality assets located in the United States and Canada. Its operations also include the marketing of oil, NGLs and natural gas. The company has two operating segments: USA Operations, and Canadian Operations. The USA Operations include the exploration for, development of, and production and marketing of oil, NGLs, natural gas and other related activities within the United States. The Canadian Operations include the exploration for, development of, and production and marketing of oil, NGLs, natural gas and other related activities within Canada.

Ovintiv Inc

JMP Securities analyst Brian Fitzgerald maintains Raymond James Finl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RJF#NYSE">RJF</a>) with a Market Outperform and raises the price target from $175 to $180.

News

Price Target

Analyst Ratings

JMP Securities Maintains Market Outperform on Raymond James Finl, Raises Price Target to $180

Fastenal Co. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FAST#NASDAQ">FAST</a>) shares jumped Monday after the company reported <a href="https://www.benzinga.com/pressreleases/25/07/b46387931/fastenal-company-reports-2025-second-quarter-earnings">stronger-than-expected second-quarter 2025 results</a>.
The industrial supplies distributor posted revenue of $2.08 billion, up 8.6% from a year ago and topping the $2.07 billion <a href="https://www.benzinga.com/earnings">consensus estimate</a>. The number of selling days remained unchanged from the prior year.
The increase was driven by improved customer contract signings over the past six quarters, despite ongoing sluggish market conditions. Foreign exchange rates contributed roughly 10 basis points to second-quarter 2025 sales and reduced sales by about 20 basis points in the year-ago period.
Also Read: <a href="https://www.benzinga.com/node/46386336">Fastenal, FB Financial And 3 Stocks To Watch Heading Into Monday</a>
Weighted FASTBin/FASTVend signings fell 10.2% year-over-year (YoY) to 6,458; Weighted FASTBin/FASTVend installations rose 10.8% YoY to 132,174. FAST&#8217;s Digital Footprint represented 61% of sales, an increase from 59.4% a year earlier.
Gross margin rose slightly to 45.3% of net sales, driven by modest price/cost benefits and improved fastener margins tied to product expansion and supplier programs. Operating income increased to 21% of sales, up from 20.2% in the second quarter of 2024.
Fastenal reported earnings per share of 29 cents, above the analyst expectations of 28 cents. 
Net cash from operating activities totaled $278.6 million, up 8.1% from a year earlier. That represented 84.4% of net income, down from 88.1% in the prior-year period, due to higher cash use in working capital.
For the first half of 2025, operating cash flow fell 8.8% to $540.8 million, or 86.0% of net income, compared with 100.5% a year earlier. The decline also reflected increased use of cash in operating assets and liabilities.
Capital expenditures totaled $64.3 million in the quarter, up from $52.6 million last year. Spending focused on FMI hardware, facilities, IT systems, and vehicles.
The company paid $252.5 million in dividends in the quarter and $499.1 million year to date. No shares were repurchased during either period. Total debt was $230 million at quarter-end, or 5.7% of total capital, compared with $235 million, or 6.3%, a year earlier.
Total debt stood at $230 million, or 5.7% of capital, down slightly from $235 million, or 6.3%, a year earlier.
For 2025, net capital outlays are expected to range from $250 million to $270 million, below earlier guidance but above 2024 levels. The increase reflects distribution center upgrades, delayed IT initiatives, and hardware deployments.
Fastenal declared a third-quarter cash dividend of 22 cents per share, payable August 26, 2025, to shareholders of record at the close of business on July 29, 2025. Share and per share information in this release has been adjusted following a two-for-one split effective May 21, 2025.
Price Action: FAST shares were trading higher by 3.88% at $44.95 at last check Monday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/travel/25/07/46390248/southwest-airlines-adds-st-thomas-to-growing-caribbean-network" target="_blank" rel="noreferrer noopener">Southwest Airlines Adds St. Thomas To Growing Caribbean Network</a></li>
</ul>
Photo via Shutterstock

Earnings

Movers

FAST

Fastenal Tops Q2 Expectations On Digital Growth, Contract Strength

Morgan Stanley analyst Brian Harbour maintains Performance Food Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFGC#NYSE">PFGC</a>) with a Equal-Weight and raises the price target from $93 to $96.

PFGC

Morgan Stanley Maintains Equal-Weight on Performance Food Gr, Raises Price Target to $96

<a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4467378-1&amp;h=192162599&amp;u=https%3A%2F%2Fwww.synopsys.com%2F&amp;a=Synopsys%2C+Inc.">Synopsys, Inc.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NASDAQ">SNPS</a>) today announced that it has received approval from all necessary authorities to proceed with the acquisition of ANSYS, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANSS#NASDAQ">ANSS</a>). The parties expect to close the transaction on or about Thursday, July 17, 2025,&nbsp;subject to the satisfaction or waiver of the remaining customary closing conditions.
Synopsys <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4467378-1&amp;h=3189527241&amp;u=https%3A%2F%2Fsynopsysansys.transactionfacts.com%2F&amp;a=announced+its+intention+to+acquire+Ansys">announced its intention to acquire Ansys</a>&nbsp;in a stock and cash transaction on January 16, 2024, bringing together Synopsys' pioneering silicon design and IP solutions with Ansys' broad simulation and analysis portfolio. The combination will create the leader in engineering solutions from silicon to systems, enabling customers to rapidly innovate AI-powered products.

ANSS

SNPS

Synopsys Receives Regulatory Approval To Acquire ANSYS, Deal Expected To Close July 17, 2025

UBS analyst Joseph Spak maintains Phinia (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHIN#NYSE">PHIN</a>) with a Neutral and raises the price target from $48 to $52.

PHIN

UBS Maintains Neutral on Phinia, Raises Price Target to $52

Morgan Stanley analyst John Glass maintains Wingstop (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WING#NASDAQ">WING</a>) with a Overweight and raises the price target from $350 to $367.

WING

Morgan Stanley Maintains Overweight on Wingstop, Raises Price Target to $367

JMP Securities analyst Brian Fitzgerald maintains Lazard (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LAZ#NYSE">LAZ</a>) with a Market Outperform and raises the price target from $55 to $60.

JMP Securities Maintains Market Outperform on Lazard, Raises Price Target to $60

Trading Ideas

NEGG

Newegg Commerce Shares Halted On Circuit Breaker To The Downside, Stock Now Down -21.4%

Sen. Elizabeth Warren (D-Mass.) has challenged the decision of Empower, a major retirement plan provider, to offer private equity as an investment option in workplace retirement plans.
What Happened: Warren had previously <a href="https://www.benzinga.com/personal-finance/management/25/06/46013443/elizabeth-warren-challenges-plan-to-bring-private-equity-into-401ks-citing-transparency-and-fee-concerns">sent a letter </a>to Empower questioning its recent decision to allow plan sponsors to include private equity investments for their employees.
Empower, which serves around 90,000 employers, has justified its move by likening it to the introduction of 401(k) plans decades ago. CEO Ed Murphy highlighted the importance of making private markets more accessible, pointing to the increasing flow of capital into private companies and the estimated $13 trillion held in global private equity assets, <a href="https://edition.cnn.com/2025/07/12/business/elizabeth-warren-empower-private-equity-401k">CNN</a> reported.
Warren, however, was not convinced. She expressed concerns about the lack of transparency and high costs associated with private equity investments. She also raised doubts about Empower's capacity to safeguard plan participants and the financial system from the structural risks inherent in private markets.
"Your response did not meaningfully address how you would shield plan participants, and our financial system, from the structural risks inherent in private markets. Ultimately, you did not explain why providing retirees with the option to invest their hard-earned life-savings in risky, expensive private markets benefits anyone other than private funds."
In her letter to Empower on Saturday, Warren expressed concerns about the company's partnerships with private firms, its fee structures, and its incentives. She asked the company to respond to her detailed questions by Friday, July 25, 2025.
SEE ALSO: <a href="https://benzinga.com/markets/tech/25/07/46384871/tucker-carlson-asks-how-did-well-connected-and-super-aggressive-bill-ackman-get-his-9-billion-pershing-square-founder-fires-back-at-epstein-smear-owes-me-an-apology" target="_blank" rel="noreferrer noopener">Tucker Carlson Asks How Did &#8216;Well-Connected And Super Aggressive&#8217; Bill Ackman Get His $9 Billion, Pershing Square Founder Fires Back At Epstein Smear: &#8216;Owes Me An Apology&#8217; &#8211; Benzinga</a>
Why It Matters: Traditionally, private companies have been the investment territory of institutional and high-net-worth investors. But as these companies play an increasingly important role in the broader investment landscape, there are growing calls to democratize access to such opportunities.
Earlier in May, it was reported that President Donald Trump was considering a new executive order that would push U.S. agencies to let private equity firms tap into the country&#8217;s huge 401(k) savings pool, which is worth almost $9 trillion. Trump&#8217;s team was drafting an order that would direct regulators like the Labor Department, Treasury, and SEC to assess allowing 401(k) plans to invest in private capital markets, <a href="https://www.benzinga.com/news/25/05/45536753/trump-eyes-retirement-overhaul-that-could-push-billions-from-401ks-into-high-stakes-private-equity-funds-report">according to the Financial Times</a>.
Warren&#8217;s recent move to challenge Empower&#8217;s decision aligns with her previous stance on the matter and adds to the ongoing debate about the inclusion of private equity in retirement plans.
READ MORE: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/politics/25/07/46381621/elizabeth-warren-once-warned-that-dogecoin-is-for-speculators-and-fly-by-night-investors-today-asset-managers-are-racing-to-bring-doge-etfs-to-wall-street">Elizabeth Warren Once Warned that Dogecoin Is for &#8216;Speculators And Fly-By-Night Investors&#8217; — Today, Asset Managers Are Racing To Bring DOGE ETFs To Wall Street</a> </li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Elizabeth Warren Grills Retirement Giant Empower Over Private Equity In 401(k) Plans: 'How You Would Shield Plan Participants...'

Morgan Stanley analyst John Glass maintains Wendy's (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WEN#NASDAQ">WEN</a>) with a Underweight and lowers the price target from $13 to $11.

Morgan Stanley Maintains Underweight on Wendy's, Lowers Price Target to $11

UBS analyst Joseph Spak maintains Magna International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MGA#NYSE">MGA</a>) with a Neutral and raises the price target from $37 to $45.

UBS Maintains Neutral on Magna International, Raises Price Target to $45

Morgan Stanley analyst John Glass maintains McDonald's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCD#NYSE">MCD</a>) with a Equal-Weight and raises the price target from $324 to $326.

Morgan Stanley Maintains Equal-Weight on McDonald's, Raises Price Target to $326

<ul>
<li>&nbsp;Multiple real-world studies show consistent high effectiveness of Vocabria + Rekambys (cabotegravir + rilpivirine LA (CAB+RPV LA)) across a broad range of populations</li>
<li>Implementation science data for Apretude (cabotegravir long-acting (CAB LA) for PrEP) demonstrate 95% of participants were happy they switched from oral PrEP to CAB LA</li>
</ul>
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced data from the phase IIIb VOLITION study demonstrating that 89% (n=129/145) of eligible treatment-naïve people living with HIV opted to switch to long-acting injectable Vocabria + Rekambys (branded as Cabenuva in the US Canada and Australia) following rapid viral suppression with daily Dovato (dolutegravir/lamivudine (DTG/3TC)). Additional real-world data from other studies reinforce CAB+RPV LA's effectiveness across a broad range of populations.

Biotech

General

ViiV Reports Real-World Data For Long-Acting HIV Regimens: 89% Of Treatment-Naïve Patients Opt For Vocabria + Rekambys After Rapid Suppression; 95% Prefer Apretude Over Oral PrEP

JMP Securities analyst Brian Fitzgerald downgrades KKR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KKR#NYSE">KKR</a>) from Market Outperform to Market Perform and maintains the price target from $150 to $150.

Downgrades

JMP Securities Downgrades KKR to Market Perform, Maintains Price Target to $150

Morgan Stanley analyst John Glass maintains Jack In The Box (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JACK#NASDAQ">JACK</a>) with a Equal-Weight and lowers the price target from $31 to $25.

JACK

Morgan Stanley Maintains Equal-Weight on Jack In The Box, Lowers Price Target to $25

Morgan Stanley analyst John Glass maintains Krispy Kreme (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DNUT#NASDAQ">DNUT</a>) with a Overweight and lowers the price target from $3 to $2.5.

DNUT

Morgan Stanley Maintains Overweight on Krispy Kreme, Lowers Price Target to $2.5

UBS analyst Joseph Spak maintains Mobileye Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBLY#NASDAQ">MBLY</a>) with a Neutral and raises the price target from $15 to $18.

MBLY

UBS Maintains Neutral on Mobileye Global, Raises Price Target to $18

JMP Securities analyst Devin Ryan maintains Robinhood Markets (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>) with a Market Outperform and raises the price target from $70 to $125.

HOOD

JMP Securities Maintains Market Outperform on Robinhood Markets, Raises Price Target to $125

<ul>
<li>Tevogen.AI's model drastically reduces target analysis and has the potential to generate billions in cost savings across the healthcare system by streamlining early-stage drug discovery, reducing wet lab dependency, and accelerating timelines.</li>
<li>Beyond cost savings, Tevogen.AI leadership believes AI-driven drug discovery has the potential to generate billions in top line revenues for companies who are early adopters.</li>
<li>With virology datasets curated and alpha model created, Tevogen.AI will now apply PredicTcell to include oncology, expanding its scope and potentially accelerating cancer immunotherapy development.</li>
</ul>
WARREN, N.J., July 14, 2025 (GLOBE NEWSWIRE) -- &nbsp;<a href="https://www.globenewswire.com/Tracker?data=NfGfRUSqWxtfz7QEJzH_GBtHzl4UJnX08ZBB3mp3ZQuL6WwSUD8g4xZapKPkXlXc9RDvG4TySzDqOfX17eW_jQ==">Tevogen</a> ("Tevogen Bio Holdings Inc." or "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TVGN#NASDAQ">TVGN</a>) today announced that its artificial intelligence initiative, Tevogen.AI, in collaboration with Microsoft (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) and Databricks, has successfully built the alpha version of its foundational PredicTcell&#x2122; model.
PredicTcell is powered by a robust and scalable data engineering pipeline. Utilizing machine learning and transformer architectures trained on a terabyte-scale dataset encompassing nearly a billion genetic and proteomic elements, the model enhances target discovery. Through parallel processing and distributed computing, Tevogen.AI dramatically reduces protein sequence analysis and peptide identification from months to hours.

MSFT

TVGN

Tevogen.AI Unveils PredicTcell Model Built With Microsoft And Databricks, Accelerating AI-Driven Drug Discovery And Expanding Into Cancer Immunotherapy

Press Releases

Real Estate

The Week in Canadian Press Releases: 10 Stories You Need to See

Commodities

Ovintiv to Host its 2024 Fourth Quarter and Year-End Results Conference Call and Webcast on February 27, 2025

Ovintiv Announces Closing of Uinta Asset Sale

Ovintiv Names Terri King to Board of Directors

Ovintiv Announces Closing of Montney Asset Acquisition

Ovintiv Reports Fourth Quarter and Year-End 2024 Financial and Operating Results

Ovintiv to Host its First Quarter 2025 Results Conference Call and Webcast on May 7, 2025

Ovintiv Announces Results of Annual Meeting

Ovintiv Reports First Quarter 2025 Financial and Operating Results

Ovintiv to Host its Second Quarter 2025 Results Conference Call and Webcast on July 25, 2025

TSX:OVV

Antero Resources Corporation Common Stock

Antero Resources

Chord Energy

CNX Resources

ConocoPhillips

California Resources Corporation Common Stock

California Resources

Comstock Resources

Coterra Energy

Devon Energy

EOG Resources

Expand Energy

Diamondback Energy

Hess

Magnolia Oil & Gas Corporation Class A Common Stock

Magnolia Oil & Gas

Matador Resources

Murphy Oil

Permian Resources Corporation Class A Common Stock

Permian Resources

Range Resources

Tamboran Resources Corporation Common stock

Tamboran Resources

Texas Pacific Land Corporation Common Stock

Texas Pacific Land

Venture Global, Inc. Class A common stock

Venture Global

Vista Energy S.A.B. de C.V. American Depositary Shares, each representing one series A share, with no par value

Vista Energy

Viper Energy, Inc. - Class A Common Stock

Viper Energy

Woodside Energy Group Limited American Depositary Shares, each representing one Ordinary Share

Comments

Ovintiv

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL